anonymous
Guest
anonymous
Guest
It’s based on $$ and obviously not on product portfolio. We still don’t even have a porous knee. Exactech has to be the play now and they better hurry too!
Sorry but this is not happening. Stryker doesn’t announce an agreement to purchase wright unless its signed up tightly. That company doesn’t operate on chance and Kevin Lobo is the alpha of MedTech right now, no way this happens. Back to your allergy cases losers.Hold everything! Damn Skip may pull this off after all? This is a make or break moment for S&N.
The regulatory filing says there’s a $150M Fee to back out... that’s a drop in the bucketSorry but this is not happening. Stryker doesn’t announce an agreement to purchase wright unless its signed up tightly. That company doesn’t operate on chance and Kevin Lobo is the alpha of MedTech right now, no way this happens. Back to your allergy cases losers.
If it’s operations We will take them back Please. please PLEASE kick Gladwell’s ass out and bring em backWright is Pro Stryker all the way.
If the S&N rejects at Cherry Road are indicative of the upper management at S&N, we'll pass.
Thanks but no thanks!
If it’s operations We will take them back Please. please PLEASE kick Gladwell’s ass out and bring em back
They can start Monday.Not all of them, just need Regan, Burcky, and Gleneck back.
Not all of them, just need Regan, Burcky, and Gleneck back.
Is S&N feeling good about this? Not much information in the news about the offer or what’s going to happen.